Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reactive vs. Proactive Pain Control in Hospitalized Patients With Inflammatory Bowel Disease

NCT03798405 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT03798405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03798405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reactive vs. Proactive Pain Control in Hospitalized Patients With Inflammatory Bowel Disease
Lead sponsor
Cedars-Sinai Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
January 1, 2019
Completion date
July 1, 2022
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, inflammatory bowel diseases, opioid use, pain, ulcerative colitis